Back
Speaker illustration

undefined undefined undefined

Presentations

One-year cardiovascular outcomes before and after GLP-1 ra discontinuation: a real-world retrospective cohort study

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Prognostic factors and outcomes in chronic coronary syndromes

Access
Like
Thumbnail

Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Comorbidities and heart failure therapies

Access
Like
Thumbnail

The impact of GLP-1 receptor agonists on cognitive decline in heart failure patients: a retrospective cohort study using real world data

Event: ESC Congress 2025

Topic: Comorbidities

Session: Optimising care of comorbidities in heart failure

Access
Like
Thumbnail

Diuretic and renal effects of spironolactone and heart failure hospitalizations: A TOPCAT Americas analysis

Event: ESC Congress 2019

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: New treatment studies in heart failure

Access
Like
Thumbnail

Medications profile post hospitalization for acute heart failure

Event: Heart Failure 2019

Topic: Other

Session: How to integrate new technologies in the heart failure clinic

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources